Loading clinical trials...
Loading clinical trials...
Obstructive sleep apnea syndrome (OSA) is a disease affecting 5-15% of population and 50-80% of type 2 diabetes mellitus (T2DM) and obese subjects. OSA causally contributes to the development of gluco...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Faculty Hospital Kralovske Vinohrady
NCT07376343 · OSA - Obstructive Sleep Apnea
NCT06722755 · Stroke Patients, CPAP, and more
NCT06430957 · Obstructive Sleep Apnea Risk Management, Postoperative Complications, and more
NCT07292922 · Obstructive Sleep Apnea (OSA)
NCT07225686 · Obesity, Obstructive Sleep Apnea
FN Kralovske Vinohrady
Prague
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions